FDA Says Biosimilar Sponsors Should Include Reference Product on Labeling

Biosimilar sponsors need to include the name of the reference product in labeling if the label includes clinical data derived from that product, the FDA said in a final guidance released Wednesday.
Source: Drug Industry Daily